• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过重叠权重解决极端倾向评分。

Addressing Extreme Propensity Scores via the Overlap Weights.

机构信息

Department of Biostatistics and Bioinformatics, School of Medicine, Duke University, Durham, North Carolina.

Department of Statistical Science, Trinity College of Arts and Sciences, Duke University, Durham, North Carolina.

出版信息

Am J Epidemiol. 2019 Jan 1;188(1):250-257. doi: 10.1093/aje/kwy201.

DOI:10.1093/aje/kwy201
PMID:30189042
Abstract

The popular inverse probability weighting method in causal inference is often hampered by extreme propensity scores, resulting in biased estimates and excessive variance. A common remedy is to trim patients with extreme scores (i.e., remove them from the weighted analysis). However, such methods are often sensitive to the choice of cutoff points and discard a large proportion of the sample. The implications for bias and the precision of the treatment effect estimate are unclear. These problems are mitigated by a newly developed method, the overlap weighting method. Overlap weights emphasize the target population with the most overlap in observed characteristics between treatments, by continuously down-weighting the units in the tails of the propensity score distribution. Here we use simulations to compare overlap weights to standard inverse probability weighting with trimming, in terms of bias, variance, and 95% confidence interval coverage. A range of propensity score distributions are considered, including settings with substantial nonoverlap and extreme values. To facilitate practical implementation, we further provide a consistent estimator for the standard error of the treatment effect estimated using overlap weighting.

摘要

在因果推断中,常用的反概率加权方法常常受到极端倾向得分的阻碍,导致有偏估计和方差过大。一种常见的补救方法是对极端得分的患者进行修剪(即从加权分析中删除他们)。然而,这种方法往往对截止点的选择很敏感,并且会丢弃很大一部分样本。对于处理效果估计的偏差和精度的影响尚不清楚。这些问题通过一种新开发的方法得到缓解,即重叠加权法。重叠权重通过在处理之间观察到的特征最重叠的目标人群中不断降低倾向得分分布尾部的单位权重,来强调目标人群。在这里,我们使用模拟来比较重叠权重与带有修剪的标准逆概率加权在偏差、方差和 95%置信区间覆盖方面的差异。考虑了一系列倾向得分分布,包括具有大量非重叠和极端值的情况。为了便于实际实施,我们进一步提供了使用重叠加权法估计处理效果的标准误差的一致估计量。

相似文献

1
Addressing Extreme Propensity Scores via the Overlap Weights.通过重叠权重解决极端倾向评分。
Am J Epidemiol. 2019 Jan 1;188(1):250-257. doi: 10.1093/aje/kwy201.
2
Addressing Extreme Propensity Scores in Estimating Counterfactual Survival Functions via the Overlap Weights.通过重叠权重解决极端倾向评分对反事实生存函数估计的影响。
Am J Epidemiol. 2022 May 20;191(6):1140-1151. doi: 10.1093/aje/kwac043.
3
Propensity score weighting under limited overlap and model misspecification.倾向评分加权在有限重叠和模型误设定下。
Stat Methods Med Res. 2020 Dec;29(12):3721-3756. doi: 10.1177/0962280220940334. Epub 2020 Jul 21.
4
Propensity Score Weighting and Trimming Strategies for Reducing Variance and Bias of Treatment Effect Estimates: A Simulation Study.倾向评分加权和修剪策略可减少治疗效果估计的方差和偏差:一项模拟研究。
Am J Epidemiol. 2021 Aug 1;190(8):1659-1670. doi: 10.1093/aje/kwab041.
5
Propensity scores used as overlap weights provide exact covariate balance.倾向得分用作重叠权重可提供精确的协变量平衡。
Eur J Cardiothorac Surg. 2024 Sep 2;66(3). doi: 10.1093/ejcts/ezae318.
6
Propensity score weighting analysis and treatment effect discovery.倾向评分加权分析与处理效应发现。
Stat Methods Med Res. 2019 Aug;28(8):2439-2454. doi: 10.1177/0962280218781171. Epub 2018 Jun 19.
7
Using Balancing Weights to Target the Treatment Effect on the Treated when Overlap is Poor.使用平衡权重来针对重叠较差时的处理效果。
Epidemiology. 2023 Sep 1;34(5):637-644. doi: 10.1097/EDE.0000000000001644. Epub 2023 Jun 21.
8
Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis.倾向评分加权使用重叠权重:一种新方法应用于瑞戈非尼临床数据和成本效益分析。
Value Health. 2019 Dec;22(12):1370-1377. doi: 10.1016/j.jval.2019.06.010. Epub 2019 Aug 20.
9
Balancing versus modelling in weighted analysis of non-randomised studies with survival outcomes: A simulation study.加权分析非随机生存结局研究中平衡与建模:一项模拟研究。
Stat Med. 2024 Jul 30;43(17):3140-3163. doi: 10.1002/sim.10110. Epub 2024 May 27.
10
Subclassification estimation of the weighted average treatment effect.加权平均处理效应的细分估计。
Biom J. 2021 Dec;63(8):1706-1728. doi: 10.1002/bimj.202000310. Epub 2021 Jul 16.

引用本文的文献

1
Calibrated and Conformal Propensity Scores for Causal Effect Estimation.用于因果效应估计的校准共形倾向得分
Uncertain Artif Intell. 2024 Jul;2024:1083-1111. Epub 2024 Jul 15.
2
: A Principled Approach to Characterizing the Underrepresented Population.一种描述代表性不足人群的原则性方法。
J Am Stat Assoc. 2025 Jun 24. doi: 10.1080/01621459.2025.2495319.
3
Propensity score weighting with survey weighted data when outcomes are binary: a simulation study.当结局为二元变量时,使用调查加权数据进行倾向得分加权:一项模拟研究。
Health Serv Outcomes Res Methodol. 2024 Sep;24(3):327-347. doi: 10.1007/s10742-023-00317-y. Epub 2023 Nov 18.
4
Subgroup-Specific Osteoporosis Risk in Chronic Kidney Disease: Insights from a Nationwide Korean Cohort.慢性肾脏病中特定亚组的骨质疏松风险:来自韩国全国队列的见解
Biomedicines. 2025 Aug 11;13(8):1956. doi: 10.3390/biomedicines13081956.
5
Association Between Fixed-Dose Combination Use and Medication Adherence, Health Care Utilization, and Costs Among Medicaid Beneficiaries.医疗补助受益人群中固定剂量复方药物使用与药物依从性、医疗保健利用及费用之间的关联
JACC Adv. 2025 Aug 21;4(9):102091. doi: 10.1016/j.jacadv.2025.102091.
6
Effectiveness of remdesivir for hospitalized COVID-19 patients depending on the severity of respiratory status: a multicenter retrospective study in Japan.瑞德西韦对不同呼吸状态严重程度的住院COVID-19患者的疗效:日本一项多中心回顾性研究
BMC Infect Dis. 2025 Aug 13;25(1):1016. doi: 10.1186/s12879-025-11345-z.
7
Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗接种状况与医护人员流感样疾病风险及工作日损失的关联。
Commun Med (Lond). 2025 Aug 9;5(1):347. doi: 10.1038/s43856-025-01046-8.
8
Amivantamab versus standard therapies among patients with advanced non-small cell lung cancer and epidermal growth factor receptor exon 20 insertion mutations after platinum-based therapy in China.在中国,铂类治疗后晚期非小细胞肺癌和表皮生长因子受体外显子20插入突变患者中,阿米万他单抗与标准疗法的对比研究。
BMC Pulm Med. 2025 Aug 1;25(1):364. doi: 10.1186/s12890-025-03826-3.
9
Inverse probability weighting for causal inference in hierarchical data.分层数据中因果推断的逆概率加权法。
BMC Med Res Methodol. 2025 Aug 1;25(1):185. doi: 10.1186/s12874-025-02627-w.
10
Corticosteroids in immunocompromised ICU patients with severe COVID-19: a multicenter retrospective study.免疫功能低下的重症新型冠状病毒肺炎重症监护病房患者使用皮质类固醇:一项多中心回顾性研究。
Sci Rep. 2025 Jul 26;15(1):27252. doi: 10.1038/s41598-025-10864-8.